Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham R Ball

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Clinical Proteomics|September 21, 2011
A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: stem cell and melanoma cancer studiesDong L Tong, David J Boocock, Clare Coveney, et al.
American Journal of Cancer Research|March 9, 2022
Upregulation of Cyclin B2 (<i>CCNB2</i>) in breast cancer contributes to the development of lymphovascular invasionAbrar I Aljohani, Michael S Toss, Khloud A El-Sharawy, et al.
Artificial Intelligence in Medicine|June 25, 2013
A quantifier-based fuzzy classification system for breast cancer patientsDaniele Soria, Jonathan M Garibaldi, Andrew R Green, et al.
Plos One|January 7, 2014
DACH1: its role as a classifier of long term good prognosis in luminal breast cancerDesmond G Powe, Gopal Krishna R Dhondalay, Christophe Lemetre, et al.
International Journal of Colorectal Disease|July 9, 2011
MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive diseaseKah Hoong Chang, Nicola Miller, Elrasheid A H Kheirelseid, et al.
Frontiers in Immunology|February 9, 2024
The 'analysis of gene expression and biomarkers for point-of-care decision support in Sepsis' study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discriminationTamas Szakmany, Eleanor Fitzgerald, Harriet N Garlant, et al.
Oncotarget|January 20, 2018
The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2Tarek M A Abdel-Fatah, Robert C Rees, A Graham Pockley, et al.
Breast (Edinburgh, Scotland)|May 3, 2011
Calpastatin is associated with lymphovascular invasion in breast cancerSarah J Storr, Rabab A A Mohammed, Caroline M Woolston, et al.
Breast Cancer Research and Treatment|October 12, 2012
TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcomeMohammed A Aleskandarany, Ola H Negm, Emad A Rakha, et al.
Molecular Cancer Therapeutics|November 13, 2016
Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast CancersArvind Arora, Swetha Parvathaneni, Mohammed A Aleskandarany, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Proteomics|September 21, 2011
A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: stem cell and melanoma cancer studiesDong L Tong, David J Boocock, Clare Coveney, et al.
American Journal of Cancer Research|March 9, 2022
Upregulation of Cyclin B2 (<i>CCNB2</i>) in breast cancer contributes to the development of lymphovascular invasionAbrar I Aljohani, Michael S Toss, Khloud A El-Sharawy, et al.
Artificial Intelligence in Medicine|June 25, 2013
A quantifier-based fuzzy classification system for breast cancer patientsDaniele Soria, Jonathan M Garibaldi, Andrew R Green, et al.
Plos One|January 7, 2014
DACH1: its role as a classifier of long term good prognosis in luminal breast cancerDesmond G Powe, Gopal Krishna R Dhondalay, Christophe Lemetre, et al.
International Journal of Colorectal Disease|July 9, 2011
MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive diseaseKah Hoong Chang, Nicola Miller, Elrasheid A H Kheirelseid, et al.
Frontiers in Immunology|February 9, 2024
The 'analysis of gene expression and biomarkers for point-of-care decision support in Sepsis' study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discriminationTamas Szakmany, Eleanor Fitzgerald, Harriet N Garlant, et al.
Oncotarget|January 20, 2018
The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2Tarek M A Abdel-Fatah, Robert C Rees, A Graham Pockley, et al.
Breast (Edinburgh, Scotland)|May 3, 2011
Calpastatin is associated with lymphovascular invasion in breast cancerSarah J Storr, Rabab A A Mohammed, Caroline M Woolston, et al.
Breast Cancer Research and Treatment|October 12, 2012
TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcomeMohammed A Aleskandarany, Ola H Negm, Emad A Rakha, et al.
Molecular Cancer Therapeutics|November 13, 2016
Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast CancersArvind Arora, Swetha Parvathaneni, Mohammed A Aleskandarany, et al.
Pageof 4